Natural killer cells in infection and inflammation of the lung

FJ Culley - Immunology, 2009 - Wiley Online Library
The lungs are a major site of entry of pathogens into the body and thus require rapid and
effective innate responses to prevent pathogens establishing infection and to limit their …

Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment

A Kaur, SK Mathai, DA Schwartz - Frontiers in medicine, 2017 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial
pneumonia (IIP), is characterized by irreversible scarring of the lung parenchyma and …

Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury

DR Calabrese, E Aminian, B Mallavia… - The Journal of …, 2021 - Am Soc Clin Investig
Pulmonary ischemia-reperfusion injury (IRI) is a clinical syndrome of acute lung injury that
occurs after lung transplantation or remote organ ischemia. IRI causes early mortality and …

NK cells in the human lungs

B Hervier, J Russick, I Cremer, V Vieillard - Frontiers in immunology, 2019 - frontiersin.org
The lung offers one of the largest exchange surfaces of the individual with the elements of
the environment. As a place of important interactions between self and non-self, the lung is …

Molecular mechanisms in progressive idiopathic pulmonary fibrosis

MP Steele, DA Schwartz - Annual review of medicine, 2013 - annualreviews.org
There is clear evidence that environmental exposures and genetic predisposition contribute
to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cigarette smoking increases the …

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia

TE Fingerlin, W Zhang, IV Yang, HC Ainsworth… - BMC genetics, 2016 - Springer
Background Fibrotic idiopathic interstitial pneumonias (fIIP) are a group of fatal lung
diseases with largely unknown etiology and without definitive treatment other than lung …

[HTML][HTML] Focus: Infectious Diseases: Role of Microbial Agents in Pulmonary Fibrosis

OS Chioma, WP Drake - The Yale journal of biology and medicine, 2017 - ncbi.nlm.nih.gov
Pulmonary fibrosis is a form of lung disease that develops due to aberrant wound-healing
following repeated alveoli injury in genetically susceptible individuals, resulting in chronic …

Blood transcriptomics predicts progression of pulmonary fibrosis and associated natural killer cells

Y Huang, JM Oldham, SF Ma, A Unterman… - American Journal of …, 2021 - atsjournals.org
Rationale: Disease activity in idiopathic pulmonary fibrosis (IPF) remains highly variable,
poorly understood, and difficult to predict. Objectives: To identify a predictor using short-term …

The influence of innate lymphoid cells and unconventional T cells in chronic inflammatory lung disease

JG Borger, M Lau, ML Hibbs - Frontiers in Immunology, 2019 - frontiersin.org
The lungs are continuously subjected to environmental insults making them susceptible to
infection and injury. They are protected by the respiratory epithelium, which not only serves …

Potential of resveratrol in the treatment of interstitial lung disease

R Huo, X Huang, Y Yang, Y Yang, J Lin - Frontiers in Pharmacology, 2023 - frontiersin.org
Interstitial lung disease (ILD) is a heterogeneous group of diseases characterized by lung
injury caused by lung fibroblast proliferation, interstitial inflammation, and fibrosis. Different …